Source of funds
What are some of the biggest challenges that investors face when it comes to source of funds?
Most investors who have not done much research on the requirements of source of funds believe that if their funds are deposited in a commercial bank, they would not have a problem. This is obviously not true. USCIS wants to know how those funds came into their account in the bank. What kind of property was sold and at what price? When was the property that was sold purchased? How was it purchased? How were the funds that were used to purchase the property earned? Unfortunately, in many developing countries transactions are consummated in cash. Even if the taxes due from those commercial transactions are paid, it is very difficult for investors to document those. That is why we strongly advise our clients to consult with their immigration attorneys. The investors should give their attorneys the whole picture so that the attorney could advise them the best path to take in terms of which moneys to use to fund the EB5 investment.
Subscribe for News
This website is for informational purposes only and does not constitute an offer or solicitation to sell shares or securities. Any such offer or solicitation will be made only by means of an investment's confidential Offering Memorandum and in accordance with the terms of all applicable securities and other laws. This website does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or any invitation to offer to buy or subscribe for, any securities, nor should it or any part of it form the basis of, or be relied on in any connection with, any contract or commitment whatsoever. EB5Projects.com LLC and its affiliates expressly disclaim any and all responsibility for any direct or consequential loss or damage of any kind whatsoever arising directly or indirectly from: (i) reliance on any information contained in the website, (ii) any error, omission or inaccuracy in any such information or (iii) any action resulting therefrom.